This biotech small-cap's grown its dividend by 140% since 2016! So with an 8.3% yield, is now the time to add it to my Stocks ...
AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...
Data suggest that remote patient monitoring may support outpatient step-up dosing of bispecific antibodies by enabling earlier CRS detection.
In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results